Navigation Links
Northern Fertility & Reproductive Associates Adds Two Local Infertility Specialists to Staff, Opens New Offices In Center City And Blue Bell
Date:11/7/2007

" added Dr. Castelbaum.

Northern Fertility offers a full range of infertility services from simple drug therapies to the assisted reproductive technologies, for treatment of a range of reproductive problems, including treatments for male infertility, ovulatory problems, endometriosis and unexplained infertility.

Patients interested in scheduling an appointment with Dr. Gocial or Dr. Gutmann should call Northern Fertility offices in Philadelphia (215-922-1556) or Blue Bell (215-654-1544).

Northern Fertility and Reproductive Associates, established in 1984, is a private medical practice specializing in fertility and reproductive medicine. Northern Fertility provides a range of services for women and men, including the assisted reproductive technologies (such as in vitro fertilization), egg and sperm donor programs, reproductive surgery, endometriosis care and treatment for recurrent miscarriage. The skilled team of infertility specialists at Northern Fertility includes highly trained physicians, nurses and laboratory technicians. With locations in Meadowbrook, Center City and Blue Bell, Northern Fertility serves patients throughout the Delaware Valley. For more information, please visit our website at http://www.northernfertility.com.


'/>"/>
SOURCE Northern Fertility and Reproductive Associates
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
2. Unions File Charges Against Tenet Healthcare Corporation, Three Northern California Hospitals
3. Angel Flight West Recognizes Northern California Pilots at AFW 24th Anniversary Awards
4. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
5. Dont just save her life, save her fertility
6. OHSU is part of national effort to preserve, restore fertility in women with cancer
7. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
8. Bay IVF Experts Launch One of First East-West Fertility Programs of Its Kind
9. UVA researchers find important clue to immune infertility
10. Gene Mutation Key to Infertility in Male Mice
11. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders ... presented today at the 51st Annual Meeting of ... treatment options and improved diagnostic methods for patients ... infant acute lymphoblastic leukemia, and myelofibrosis that are ...
(Date:12/5/2009)... an innovative new international private medical insurance plan which follows the ... customers the flexibility to add or remove a wide range of ... to tailor their benefits to complement those already offered in their ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ... has declared a dividend of $0.17 per share of common stock. ... shareholders of record on December 14, 2009. ,, ... is a real estate investment and finance company investing in healthcare-related ...
(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... northern Illinois is declining due to improved care for ... , But not everyone is reaping the benefits. ... of Medicine has found people in African American communities ... times higher rate of lower limb amputations than people ...
... ... oncology, MEMPHIS, ... company specializing in,oncology, issued the following statement today regarding the impact ... PRO information in the community oncology setting,and timely intervention can significantly ...
... new era of custom exercise routines online at ... TNL24-7.com officially,launched its Web-based, customizable workout software ... anyone, regardless of fitness level, to,take charge of ... TNL24-7 allows anyone to create a professional ...
... Auction, OREM, Utah, April 28 Friday,s Kids ... holding its,first annual Lifting Angels Auction the week leading ... to auction, Friday,s Kids, goal is to,raise $15,000 to ... needs. As the major fundraising campaign, the auction will,attract ...
... 28, 2008 How frequently do doctors misdiagnose patients? ... medical diagnoses are correct, the answer is probably higher ... In a Supplement to the May issue of The ... commentaries sheds light on the causes underlying misdiagnoses and ...
... NORTH HOLLYWOOD, Calif., April 28 IPC The,Hospitalist Company, ... practice company, announced today that Adam D. Singer, Chief,Executive ... 2008 at the,33rd Annual Deutsche Bank Health Care Conference ... will also be present at the,conference., Event: ...
Other Medicine News:Health News:African Americans have 5 times higher amputation rate 2Health News:Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care 2Health News:Friday's Kids Respite Holds Fundraising Event to Help Children with Special Needs 2Health News:Will you be misdiagnosed? -- how diagnostic errors happen 2Health News:Will you be misdiagnosed? -- how diagnostic errors happen 3Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2
(Date:12/4/2009)... DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC ... has been enrolled in the company,s Phase II-b, dose ... emulsion in traumatic brain injury (TBI). Oxycyte is the ... is of invaluable importance in improving the outcome of ...
(Date:12/4/2009)... 4 Shared Imaging, LLC, an independent provider ... programs for hospitals and healthcare providers, is excited ... Accreditation for Ambulatory Health Care, a nationally-recognized, prestigious ... in patient care. Shared Imaging accreditation is system-wide ...
(Date:12/4/2009)... highlighted a new report published by the ... that identifies 97 new drugs and vaccines in development for ... that the 97 products in development include 23 vaccines and ... or awaiting approval by the U.S. Food and Drug Administration ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2For Healthy Aging Maintaining Muscle is a Must 54179 1For Healthy Aging Maintaining Muscle is a Must 54179 2For Healthy Aging Maintaining Muscle is a Must 54179 3Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 1Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 2Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 3Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 4Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 5Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 6Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 7Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 8Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook 13497 9Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 1Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 2Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 3
... highly selective PI3K-inhibition which could be valuable ... - AEterna Zentaris,Inc. , a global, pure ... oncology, today presented an abstract,outlining first in ... selectivity for PI3K inhibition, at the American,Association ...
... Spain--(BUSINESS WIRE)--Apr 14, 2007 - In a ... the European Association,for the Study of the ... planned interim analysis of the PROVE 1 ... evaluate short-duration therapy with,the investigational hepatitis C ...
Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
... ResMeds premium APAP device in the S8 ... patients pressure needs on a breath-by-breath basis. ... fully integrated humidification and also include remote ... patients time by reducing medical visits. Like ...
... AutoSet Spirit is the premium APAP device ... S7. The AutoSet algorithm responds to the ... The flow generator stores and reports comprehensive ... The AutoSet devices combine integrated humidification and ...
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: